Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2019	Mar. 31, 2018
Revenue	$ 64,677	$ 66,367	$ 204,136	$ 138,331
Operating expenses
Cost of goods sold	1,042	0	2,023	0
Research and development	65,541	71,348	183,211	180,881
Selling, general and administrative	35,548	16,773	90,911	40,428
Total operating expenses	102,131	88,121	276,145	221,309
Loss from operations	(37,454)	(21,754)	(72,009)	(82,978)
Other income (expense)
Interest income	2,912	1,295	6,722	3,075
Interest expense	(2,863)	(2,361)	(8,261)	(8,407)
Loss on extinguishment and conversion of notes	0	0	0	(6,457)
Change in fair value of notes payable	0	(100)	(65)	(200)
Other, net	(89)	69	(54)	69
Total other income (expense), net	(40)	(1,097)	(1,658)	(11,920)
Net loss	(37,494)	(22,851)	(73,667)	(94,898)
Change in unrealized gain (loss) on marketable securities	274	(81)	626	(681)
Comprehensive loss	$ (37,220)	$ (22,932)	$ (73,041)	$ (95,579)
Weighted average shares outstanding – basic (in shares)	219,913	208,994	215,964	194,434
Weighted average shares outstanding – diluted (in shares)	219,913	208,994	215,964	194,434
Net loss per share – basic (in dollars per share)	$ (0.17)	$ (0.11)	$ (0.34)	$ (0.49)
Net loss per share – diluted (in dollars per share)	$ (0.17)	$ (0.11)	$ (0.34)	$ (0.49)
Product sales, net
Revenue	$ 35,078	$ 0	$ 71,784	$ 0
Product royalties
Revenue	937	0	1,261	0
Collaboration and license revenue
Revenue	19,493	41,616	101,121	72,993
Reimbursement revenue
Revenue	$ 9,169	$ 24,751	$ 29,970	$ 65,338